Science & Research

Clinical Trials and Human Subject Protection

Adherence to the principles of good clinical practice (GCP), including human subject protection (HSP), is universally recognized as a critical requirement to the ethical conduct of research involving human subjects. The Food and Drug Administration (FDA) regulations for the conduct of clinical trials, which have been in effect since the 1970s, address both GCP and HSP. FDA regulations and guidance documents, and international GCP guidance documents on which FDA has collaborated, and that have been adopted as official FDA guidance, are also found here.

Office of Good Clinical Practice

The Office of Good Clinical Practice (OGCP) serves as the FDA focal point for GCP and HSP issues related to FDA-regulated clinical trials. OGCP sets priorities for the development of GCP and HSP policy, works to ensure consistency in GCP and HSP policy across the agency, participates in international GCP and HSP harmonization activities, and serves as liaison to other Federal agencies and external stakeholders committed to the protection of human research participants. (For more information, see
OGCP's mission statement.)


Subscribe

Sign up for Good Clinical Practice/Human Subject Protection e-mail updates


Bioresearch Monitoring

FDA’s bioresearch monitoring program conducts on-site inspections of both clinical and nonclinical studies performed to support research and marketing applications/submissions to the agency. Links to the compliance programs for each inspection type are accessible from this site

Workshops, Meetings, and Conferences

In The News

Contact FDA

Office of Good Clinical Practice

Food and Drug Administration

Office of Good Clinical Practice

Office of Special Medical Programs

10903 New Hampshire Ave., WO32-5103

Silver Spring, MD 20993

Page Last Updated: 03/05/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English